Human Tissue (Authorisation) (Scotland) Bill - written submissions received

Additional Written Evidence

Following our formal evidence session on 6 November 2018, we received additional written evidence from Fiona Loud, Policy Director, Kidney Care UK: 

Following our formal evidence session on 20 November 2018, we received additional written evidence from Dr Frank Atherton, Chief Medical Officer NHS Wales:

Following our formal evidence session on 27 November 2018, we received additional written evidence from Dr Calum MacKellar, Director of Research, Scottish Council on Human Bioethics:

This website is using cookies.
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website.